期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Therapeutic Advances in Medical Oncology LetPub Score 7.1
50 ratings
Rate
Reputation 8.1 Influence 6.4 Speed 6.9 | ||||||||||||||||
期刊簡稱 | THER ADV MED ONCOL | ||||||||||||||||
ISSN | 1758-8340 | ||||||||||||||||
E-ISSN | 1758-8359 | ||||||||||||||||
h-index | 34 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 2.30%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://journals.sagepub.com/home/tam | ||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/tao | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | SAGE Publications Inc. | ||||||||||||||||
主題領域 | ONCOLOGY | ||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||
發行頻率 | 継続刊行 | ||||||||||||||||
創刊年 | 2009 | ||||||||||||||||
每年文章數 | 194每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 89.69% | ||||||||||||||||
OA Related Info | APC: Yes( USD2800; ) APC waiver:Check Notes Other charges: No Keywords: oncology、cancer Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1758-8340%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 15 Weeks | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 | |
[Therapeutic Advances in Medical Oncology] 的評論 | 撰寫評論 |
作者: 水月子武 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-15 12:07:12 評論於 Administrative checks complete Initial checks have been completed and Editor assignment is being determined. This status has been maintained for 11 days, what does this mean?(0) 讚! | 水月子武 |
作者: 水月子武 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 12:07:20 評論於 May I ask for a timeline?(0) 讚! | 水月子武 |
作者: 水月子武 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-04 23:48:23 評論於 May I ask how the progress is going?(0) 讚! | 水月子武 |
作者: 水月子武 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-04 22:00:29 評論於 May I ask for the timeline?(0) 讚! | 水月子武 |
作者: 水月子武 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-04 19:04:53 評論於 How is your progress coming along?(0) 讚! | 水月子武 |
作者: 东海弘光 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-07 12:03:30 評論於 The journal recommended by my senior brother is said to have good article quality, but the number of articles published in China is relatively low. I guess it may be a bit strict. I am preparing to submit an article, mainly because I don't have to worry about it being blacklisted(0) 讚! | 东海弘光 |
作者: 深渊诗语 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-06 15:02:04 評論於 I am also still waiting for the results(0) 讚! | 深渊诗语 |
作者: 形意炜曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-05 11:07:06 評論於 The review process was very smooth, and the reviewers' comments were very professional, significantly improving the quality of the article. The review speed was fast and the editor was friendly, which was completely different from the British style. However, the innovation and linguistic level of the article still need to be improved(0) 讚! | 形意炜曦 |
作者: 极乐慕山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-01 12:02:32 評論於 The initial review and revision process took one and a half months, and the total time until acceptance confirmation was three months, which went very smoothly. I think this journal is good, with a high acceptance rate for submissions, and is worth considering!(0) 讚! | 极乐慕山 |
作者: 凤凰院正平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-16 17:26:16 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":"(0) 讚! | 凤凰院正平 |
作者: 岭南易丹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-28 20:55:08 評論於 Hey, how did your article turn out in the end? Is it under review? After receiving the reviewer invitation, mine didn't go to under review and went straight back to editor assessment. Does that mean it's not going to make it?(0) 讚! | 岭南易丹 |
作者: 岭南易丹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-28 18:13:26 評論於 Hey, how did your article turn out in the end? Is it under review? Mine went back to editor assessment after reviewer invitation without going through under review, does that mean it's not going well?(0) 讚! | 岭南易丹 |
作者: 岭南易丹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-28 12:17:21 評論於 Hello, may I ask if there is a situation where the status changes from "reviewer invitation and response being received" to "The Editor is assessing your submission for peer review"? There is no "under review" status in between, is this a bad sign? Or does it mean that reviewers have not been invited?(0) 讚! | 岭南易丹 |
作者: yayacee 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-28 11:12:00 評論於 Dear, how is the status of your article now? Is it under review? Mine also changed back to editor assessment directly after reviewer invitation, is it going to be rejected?(0) 讚! | yayacee |
作者: 五虎青亦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-11 16:44:10 評論於 Hello, I would like to ask about the final outcome of your submission(0) 讚! | 五虎青亦 |
作者: Nick Xie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-29 18:41:08 評論於 Is it normal to have Editor assessment for two months even though I have already submitted? There were intermittent Reviewer invitations in between, and then it returned to Editor assessment again.(0) 讚! | Nick Xie |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-05 14:59:52 評論於 Review Speed: 12.0 | Submission Acceptance Rate: 50.0 Emphasized Research Direction: Tumor Clinical Treatment Experience Sharing: It took 9 months from submission to final acceptance, which is a bit long. The delay might be due to the impact of the pandemic. This is just a sharing of personal experience(0) 讚! | 景焕小姐姐 |
作者: 水桥昆锐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-20 18:56:38 評論於 Bro, I'm facing a similar situation now. I wanted to ask how your article ended(0) 讚! | 水桥昆锐 |
作者: 水桥昆锐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-20 17:34:22 評論於 Bro, I also encountered this situation, just wondering how it turned out in the end(0) 讚! | 水桥昆锐 |
作者: 谷玉mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-16 12:11:35 評論於 May I ask what is the final result for you? I also received the "The Editor is assessing your submission for peer review," after 1 and a half weeks from receiving the reviewer invitation and response. Does this mean it will be rejected?(0) 讚! | 谷玉mio |
作者: 谷玉mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-16 08:16:05 評論於 Hey, I'm in the same situation. How is your paper going?(0) 讚! | 谷玉mio |
作者: 水月悦洋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-11 21:43:38 評論於 It has been almost two months for me, and I have been constantly looking for reviewers(0) 讚! | 水月悦洋 |
作者: 水月悦洋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-27 16:35:00 評論於 How are you feeling now? I also keep going back to this state(0) 讚! | 水月悦洋 |
作者: 北国爱宝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-09 08:40:24 評論於 Can you translate the following paragraph into English and Japanese, and use ":" and ":" as titles?(0) 讚! | 北国爱宝 |
作者: Woodrow Mike 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-21 10:48:49 評論於 It's been almost 2 months since submission, but there has been no response yet. Is everyone this slow?(0) 讚! | Woodrow Mike |
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 |
Contact us